Clinical Development Program Manager
Eligo Bioscience is a seven-year-old biotechnology company, spun out of MIT and Rockefeller University, and based in Paris, France.
Eligo Bioscience has raised more than 20 million euros from leading investors in Silicon Valley and France to develop next-generation drugs that are based on the genetic engineering of bacteria and their viruses and aim to address unmet medical need in diseases associated with the microbiome.
The Company has been elected as one of the 30 Most Innovative Companies by the World Economic Forum in 2017, has received multiple international awards for pioneering work in the field of synthetic biology, and has been featured in international media and scientific journals such as Nature Biotechnology, Science, The Economist, The BBC and The New York Times.
Eligo Bioscience has attracted highly diverse top talent from all over the world, currently numbering over 40 Eligonauts from more than 10 countries, who are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to save lives and treat chronic disease. Our pipeline is rapidly progressing towards the clinic and we are expanding our clinical development team and further building our clinical excellence.
Eligo embraces diversity, equal opportunity and inclusion and is committed to building diverse teams. We strive to create an inclusive workplace that cultivates innovation through collaboration and empowers people to unleash their full potential.
At Eligo Bioscience, we are passionate about developing new drugs to address unmet medical needs! We are looking for a high-performing and enthusiastic Clinical Development Program Manager to partner with the Clinical Development Program Lead to progress our most advanced program into the clinic and prepare the entry into clinical development of our other programs. Our growing pipeline is in the area of infection, autoimmunity and cancer and we are seeking talented experts with affiliation with these disease areas. Our lead program aims to treat patients infected with Shiga toxin-producing E. coli, a life-threatening and debilitating infection which can escalate into Hemolytic Uremic Syndrome. We believe that our lead asset EB003 has the potential to drastically change the disease course and outcome, and as a Clinical Development Program Manager you will play a central role in bringing this therapeutic opportunity to patients.
The Clinical Development Program Manager drives execution of the program, coordinates the program objectives and, in concert with the Clinical Development Program Lead, is accountable for achieving successful delivery of the EB003 program team activities at the program level, by meeting company and regulatory requirements with respect to time, quality, scope and budget.